Document is current
Any future updates will be listed below
-
Authors
Berger, Michael
Seemüller, Florian
Voggt, Alessandra
Obermeier, Michael
Kirchberg, Franca
Löw, Anja
Riedel, Michael
von Schacky, Clemens
Severus, Emanuel http://orcid.org/0000-0002-9135-1679
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00891826 at ClinicalTrials.govDocuments that mention this clinical trial
Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: the “BIPO-3” trial
https://doi.org/10.1186/s40345-022-00253-9
-
Funding
Funding for this research was provided by:
EPAX AS
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- License Information
-
More Information
Article History
Received: 23 August 2021
Accepted: 31 January 2022
First Online: 1 April 2022
Declarations
:
: The present trial was approved by the ethics’ committee of the medical faculty of the Ludwig-Maximilians-University, Munich. The trial is registered at ClinicalTrials.gov, number NCT00891826.
: Not applicable.
: MB, FS, AV, MO, FFK, AL, MR, ES: no competing interests. CvS: operates Omegametrix, a laboratory for fatty acid analyses. CvS received honoraria for consulting and/or speaking from BASF/Pronova, Huntsworth Medical, EPAX, and Norsan.
